Position in MRK
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$7,051,437
+$474,582 QoQ
Shares Held
54,875
+0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
5.64%
of 13F equity value
Holder Rank
#885
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cairn Investment Group, Inc. holds $15,565,541 across 7 Drug Manufacturers - General names. MRK ranks #1 (45.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
54,875 | $7,051,437 | |
| 2 | LLY |
ELI LILLY & Co
|
2,610 | $3,130,512 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
21,247 | $2,684,345 | |
| 4 | BIIB |
Biogen Inc.
|
8,043 | $1,737,770 | |
| 5 | NVO |
Novo Nordisk A S
|
9,333 | $447,424 | |
| 6 | JNJ |
Johnson & Johnson
|
1,060 | $269,208 | |
| 7 | ABBV |
AbbVie Inc.
|
973 | $244,845 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,051,437 | 54,875 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $6,576,855 | 54,675 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $5,784,563 | 54,955 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $4,616,569 | 55,005 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $4,320,948 | 54,585 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $314,160 | 3,500 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $348,180 | 3,500 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $397,460 | 3,500 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $461,155 | 3,725 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $461,825 | 3,500 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $381,570 | 3,500 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $380,400 | 3,695 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $403,865 | 3,500 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $372,365 | 3,500 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $424,605 | 3,827 | Shares | Sole | 2023-01-11 | |
| 2022-09-30 | $301,420 | 3,500 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $364,680 | 4,000 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $289,226 | 3,525 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $270,156 | 3,525 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $264,762 | 3,525 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $282,071 | 3,627 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $278,680 | 3,615 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $1,175,792 | 14,374 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $1,221,771 | 14,729 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $1,419,315 | 18,354 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,439,469 | 18,709 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||